Researcher: matthew mcdermott
Research Overview:
Matthew McDermott's research focuses on the intersection of clinical decision support and computational pathology, with a particular emphasis on the application of machine learning and artificial intelligence to enhance laboratory test ordering and address missing data issues in medical contexts. His work explores the clinical utility of biomarkers such as ferritin and plasminogen in relation to conditions like autoimmunity and venous thrombosis, integrating insights from precision medicine and computational biology. Additionally, McDermott's studies highlight challenges such as model bias, algorithm interpretability, and the need for reproducibility in machine learning frameworks. His investigations extend into the development of innovative drug delivery systems and biocompatible materials, leveraging nanotechnology and microtechnology to optimize therapeutic applications. Overall, McDermott's research contributes significantly to advancing clinical processes and therapeutic strategies through a multidisciplinary approach that marries computational techniques with clinical insights.